Heparin can artificially raise INR results, but the effect depends on the type of heparin, its concentration in your blood, and the specific reagent your lab uses for testing. In most clinical situations, the prothrombin time test (which generates the INR number) is designed to be insensitive to heparin at therapeutic levels. Problems arise when heparin concentrations are higher than expected or when certain lab reagents are more susceptible to interference.
How Heparin Interferes With INR Testing
The INR is calculated from the prothrombin time (PT) test, which measures how quickly your blood forms a clot through a specific clotting pathway. Heparin works primarily through a different part of the clotting system, which is why the PT test is generally considered insensitive to it. Most labs report that the PT remains unaffected by unfractionated heparin at concentrations up to about 2.0 units per mL of blood.
However, “insensitive” is not the same as “immune.” When heparin levels climb higher, or when a particular lab reagent happens to be more reactive to heparin’s presence, the PT result gets stretched longer than it should be. That translates directly into a falsely elevated INR. One study examining this problem found that a heparin-sensitive reagent inflated INR values by an average of 16%, with individual cases ranging from a 2% bump all the way up to 55%, depending on how much heparin was circulating in the patient’s blood.
Why a False High INR Matters
This becomes a real clinical problem when you’re taking both heparin and warfarin at the same time, which is common. Warfarin takes several days to reach its full effect, so heparin is often used as a “bridge” to provide immediate protection while warfarin builds up. During this overlap period, your care team relies on the INR to decide when warfarin has kicked in enough to safely stop the heparin.
If heparin is quietly pushing your INR reading higher than it truly is, it can look like warfarin is working sooner than it actually is. That can lead to stopping heparin too early, leaving you temporarily underprotected against blood clots. Because warfarin’s therapeutic window is narrow (an INR between 2.0 and 3.0 for most conditions), even a modest artificial bump of half a point can make the difference between a reading that looks therapeutic and one that isn’t really there yet.
During bridging therapy, INR testing typically begins on the third day of overlap and is repeated daily until the INR reaches 2.0 or above. Getting accurate readings during this window is essential for a safe transition off heparin.
Common Sources of Heparin Contamination
The most frequent cause of falsely high INR readings isn’t the heparin circulating in your bloodstream from a therapeutic dose. It’s contamination of the blood sample itself. This happens when blood is drawn from a line or catheter that has been flushed or locked with heparin solution. Even a small amount of residual heparin in the tubing can mix with the sample and throw off the result.
This is an especially well-documented problem for people on hemodialysis who have tunneled dialysis catheters. These catheters are routinely locked with concentrated heparin between sessions. When blood for INR testing is drawn from the catheter at the start of dialysis, studies have found heparin contamination above 1.0 IU/mL in more than 13% of samples. Labs will often reject samples they identify as heparin-contaminated, but the contamination isn’t always obvious.
How Labs Correct for Heparin
Modern lab reagents and point-of-care testing devices include heparin-neutralizing agents designed to cancel out low levels of heparin in a blood sample. The specific threshold varies by product. Some PT reagents use a compound called polybrene that neutralizes heparin up to 1.0 IU/mL. The CoaguChek XS, a portable device commonly used for home or bedside INR monitoring, neutralizes heparin up to about 0.8 IU/mL.
For situations where higher heparin levels are expected, labs can treat the plasma sample with an enzyme called heparinase, which breaks down heparin before the clotting test is run. This enzymatic approach has been shown to be more effective than older chemical methods at removing heparin from samples, and it can significantly improve the accuracy of INR results for patients taking both heparin and warfarin at the same time. Not every lab routinely performs this step, though, so it often needs to be specifically requested.
Low-Molecular-Weight Heparin and Other Options
Low-molecular-weight heparins (like enoxaparin) have less impact on the PT/INR than unfractionated heparin, though they are not completely free of interference at higher doses. The distinction matters because low-molecular-weight heparins are the more commonly prescribed form for outpatient use, including for bridging therapy around surgeries.
Fondaparinux, a synthetic anticoagulant sometimes used as an alternative to heparin, has no effect on the INR at all. For patients who need bridging anticoagulation and accurate INR monitoring at the same time, this can simplify things considerably. Warfarin monitoring proceeds as it normally would, without any concern about interference from the bridging drug.
Getting Accurate Results While on Heparin
If you’re on both heparin and warfarin, a few practical factors affect the reliability of your INR results. Blood samples drawn from a peripheral vein (a fresh needle stick in the arm) are far less likely to be contaminated than samples drawn from an existing IV line or catheter. If blood must come from a catheter, discarding a generous amount before collecting the test sample helps flush out residual heparin.
Timing also plays a role. Drawing the INR sample when heparin levels are at their lowest point in the dosing cycle reduces interference. For people receiving intermittent heparin infusions, that means testing just before the next dose rather than shortly after one. For those on continuous drip heparin, some protocols call for briefly pausing the infusion before drawing the sample, though this depends on your clinical situation.
If your care team suspects heparin interference, they can request that the lab use a heparinase-treated sample or a reagent with higher heparin-neutralizing capacity. Comparing results from a treated and untreated sample can also reveal whether heparin was skewing the numbers.